CVR Medical Corp V.CVM.H

Alternate Symbol(s): CRRVF

Healthcare Biotechnology

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology, such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). The CSS is 100% non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers. The CVR device uses only sound wave analysis to detect the presence of arterial stenosis.

TSXV:CVM.H - Post by User

CVR Medical Corp

Bullboard Posts

Comment by Nastroon Dec 29, 2018 4:02pm

59 Views

Post# 29168344

RE:RE:RE:RE:RE:Just for Fun

If I remember rightly the company presentation about 18 months ago used to carry some quite detailed revenue assumptions. I think we’re targeting about $250m after year 2 and around $550m after year 3. This was from US sales only. Nothing from Canada in this which should come first in approval terms. Not sure why they took this slide out and I don’t know how realistic it is but I think it must be based on market research rather than just plucking figures out of the air.

However, if they are a reasonable estimate then you could actually treble this as sales from Europe and the Far East will be roughly similar and arguably greater. Think I might have that presentation printed off somewhere.

Bullboard Posts

Day trading vs. swing trading strategies for small-cap stocks